Skip to main content
Show full summary

Lord Blunkett to ask Her Majesty's Government, further to the remarks by Baroness Bloomfield of Hinton Waldrist on 23 March (HL Deb col 958), what assessment they have made of the effectiveness of existing vaccines available in the UK in (1) protecting against, or (2) reducing the impact of, Omicron (a) B4, and (b) B5; what assessment they have made of the likely availability of the improved vaccine undergoing experimentation at (i) St George's Hospital, and (ii) beyond; and on what date the fourth COVID-19 booster vaccine will be available for general use across the UK this autumn.  HL1424

Question HL1424: tabled on 4 July 2022 and due for answer by 18 July 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Blunkett to ask Her Majesty's Government, further to the remarks by Baroness Bloomfield of Hinton Waldrist on 23 March (HL Deb col 958), what assessment they have made of the effectiveness of existing vaccines available in the UK in (1) protecting against, or (2) reducing the impact of, Omicron (a) B4, and (b) B5; what assessment they have made of the likely availability of the improved vaccine undergoing experimentation at (i) St George's Hospital, and (ii) beyond; and on what date the fourth COVID-19 booster vaccine will be available for general use across the UK this autumn.  HL1424
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.